Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Ciprofloxacin impurity 1, also known as Ciprofloxacin impurity C, is a known impurity of the antibiotic Ciprofloxacin. This compound is primarily utilized in pharmaceutical research for the assessment of drug purity and quality control in ciprofloxacin formulations. Its presence in drug samples offers important insights into the synthesis and stability of ciprofloxacin, making it essential for regulatory compliance and safety evaluations in drug development. -
Drug Impurity
Methylprednisolone acetate impurity 7 is a recognized impurity associated with the corticosteroid Methylprednisolone acetate. This compound serves as a critical reference standard in pharmacological and analytical research, particularly in ensuring the purity and quality of pharmaceutical formulations. Its characterization can aid in the assessment of drug stability, efficacy, and safety profiles in various biological systems. -
Drug Impurity
(S)-2-Amino-3-(4-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoic acid serves as a drug impurity relevant to the characterization and quality control of Levothyroxine. This compound can be employed in analytical studies to identify and quantify impurities within pharmaceutical formulations. Its presence may impact the efficacy and safety of Levothyroxine, making it valuable for researchers engaged in drug development and compliance testing. -
Drug Impurity
6-Chloroconazole impurity 17 is a known impurity of the antifungal agent 6-Chloroconazole. Its identification is crucial for quality control and regulatory compliance in pharmaceutical formulations. This compound serves as a reference standard for analytical techniques, aiding in the evaluation of drug purity and stability in chemical research and development. -
Drug Impurity
Domperidone impurity 2 is a known impurity associated with the pharmaceutical compound Domperidone. As a drug impurity, it is critical for ensuring the safety and efficacy of formulations containing Domperidone. Its characterization plays a significant role in quality control during drug development and regulatory assessments. This compound is essential for research focusing on the identification and quantification of impurities in pharmaceutical products. -
Drug Impurity
Carvedilol impurity 10, also known as N-Benzylcarvedilol, is a drug impurity associated with Carvedilol. Its presence in pharmaceutical formulations is significant for studying the safety, efficacy, and quality of the main compound. This impurity is essential for analytical applications, including method development and validation, ensuring compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Citalopram impurity 10 is a drug impurity associated with the selective serotonin reuptake inhibitor Citalopram. This impurity serves as a critical analytical reference standard for pharmaceutical development and quality control, facilitating the assessment of Citalopram's purity and stability. Its presence in formulations underscores the importance of ensuring drug safety and efficacy through rigorous impurity profiling in pharmaceutical research. -
Drug Impurity
Apixaban impurity 15 is a specific impurity associated with the cardiovascular drug Apixaban, a selective factor Xa inhibitor. This compound is essential for quality control and analytical studies in pharmaceutical research and development, particularly in the assessment of drug purity and stability. Researchers utilize this impurity to investigate the degradation products and ensure compliance with regulatory standards. -
Drug Impurity
Buspirone impurity 5, also referred to as Buspirone impurity B, is a known impurity associated with the synthesis of Buspirone. This compound serves as a critical analytical standard for the assessment of drug purity and quality control in pharmaceutical research. Its identification and quantification are essential for ensuring the safety and efficacy of Buspirone formulations. -
Drug Impurity
Telmisartan impurity 12 is a recognized impurity of the antihypertensive agent Telmisartan. Its characterization is important for quality control in pharmaceutical development and formulation. This reagent is utilized in research to ensure the integrity and safety of Telmisartan-based therapies. -
Drug Intermediate
p-SCN-Bn-DOTA(tBu)4 is a derivative of DOTA that acts as a drug intermediate. It serves as a key component in the Gd(III)-DOTA-IAC, a targeted magnetic resonance imaging (MRI) contrast agent designed for the αvβ3 integrin receptor. This compound is valuable in biomedical research for developing specific imaging agents that can enhance the visualization of tumor tissues and facilitate targeted therapies. -
Drug Impurity
Metoprolol impurity 6 is a chemical impurity associated with the synthesis of Metoprolol, a selective beta-1 adrenergic antagonist. This compound can be utilized in pharmaceutical research for the characterization and quantification of impurities in drug formulations. Its analysis is essential for ensuring the safety and efficacy of Metoprolol products in clinical applications. -
Drug Impurity
Olmesartan impurity 3 is a chemical impurity associated with the angiotensin II receptor blocker, Olmesartan. It serves as an important reference standard for quality control and validation in pharmaceutical studies. This reagent is suitable for use in analytical research, including purity assessment and stability testing of drug formulations containing Olmesartan. -
Drug Impurity
Leflunomide impurity 3, a structural isomer of Leflunomide, serves as a drug impurity for quality assessment and regulatory compliance. This compound can be utilized in analytical studies to investigate the stability and purity of Leflunomide formulations. Its presence and characterization are essential for ensuring the safety and efficacy of pharmaceutical products containing Leflunomide. -
Drug Impurity
Sofosbuvir impurity 6 is a known impurity associated with the antiviral drug Sofosbuvir, which targets the hepatitis C virus polymerase. This compound is essential for analytical chemistry studies and serves as a reference standard in pharmaceutical formulations to ensure the quality and efficacy of Sofosbuvir products. Its application is critical in the development and validation of analytical methods for drug purity assessment. -
Drug Impurity
Dacomitinib impurity 16 is a chemical byproduct associated with Dacomitinib, a potent irreversible inhibitor of the epidermal growth factor receptor (EGFR). This impurity can serve as a reference standard in analytical chemistry to ensure the quality and purity of Dacomitinib during drug development. It is useful for researchers engaged in the assessment of pharmaceutical formulations and the development of related compounds. -
Drug Impurity
Afatinib impurity 7, also known as Boc-D-Arg(NO2)-OH, is a recognized impurity associated with the tyrosine kinase inhibitor Afatinib. This compound is primarily used in analytical development and quality control processes to assess the purity of Afatinib formulations. Its characterization is essential for ensuring the integrity and efficacy of pharmaceutical products containing Afatinib. -
Drug Impurity
Duloxetine impurity 8 is a chemical impurity associated with the synthesis of Duloxetine, a selective serotonin and norepinephrine reuptake inhibitor (SNRI). This compound is primarily used in pharmaceutical research to assess the purity and quality of Duloxetine formulations. Its presence can provide insights into synthetic processes and potential effects on pharmacological activity, making it valuable for drug development and regulatory compliance studies. -
Drug Impurity
Levothyroxine impurity 6 is a characterized impurity associated with Levothyroxine, primarily known for its implications in pharmaceutical quality control. This compound serves as an important reference standard for assessing the purity and stability of Levothyroxine formulations. Its analysis is critical in ensuring compliance with regulatory standards and maintaining the integrity of pharmaceutical products. -
Drug Impurity
Rosuvastatin impurity 33 is a chemical impurity associated with Rosuvastatin, a cholesterol-lowering agent that inhibits HMG-CoA reductase. This impurity is utilized primarily in pharmaceutical research to assess the purity and quality of Rosuvastatin formulations. Its presence and behavior in various formulations aid in the understanding of the drug’s stability and efficacy. -
Drug Impurity
Candesartan impurity 3 is a known impurity of the antihypertensive agent Candesartan. As a drug impurity, it plays a significant role in the assessment of the purity and quality of pharmaceutical formulations containing Candesartan. This reagent is essential for researchers focusing on drug development and validation processes, ensuring compliance with regulatory standards. -
Ciprofloxacin Impurity
N-Nitrosociprofloxacin is an impurity of the fluoroquinolone antibiotic ciprofloxacin. It is of significant interest in chemical research and analytical studies focused on drug quality and safety assessment. Understanding its properties aids in evaluating the stability and degradation pathways of ciprofloxacin in various formulations. -
Drug Impurity
Salmeterol impurity 9 is a known impurity associated with the beta-2 adrenergic agonist Salmeterol. This compound is primarily used in the analysis and quality control of Salmeterol formulations. It serves as an important reference standard for assessing the purity and stability of Salmeterol in pharmaceutical research and development. -
Promethazine Impurity
Isopromethazine hydrochloride is an impurity associated with Promethazine, a well-known N-substituted phenothiazine. This compound functions primarily as an H1-receptor antagonist, exhibiting antihistaminic properties. Isopromethazine hydrochloride is relevant for quality control and analytical studies in pharmaceutical formulations of Promethazine, aiding in the assessment of purity and consistency in drug manufacturing. -
Drug Impurity
Acyclovir impurity 8 is a structural impurity related to Acyclovir, an antiviral medication primarily used in the treatment of herpes simplex virus infections. This impurity is relevant for analytical and quality control studies in pharmaceutical development. Understanding the chemical profile and behavior of drug impurities is crucial for ensuring the safety and efficacy of antiviral therapies. -
Drug Impurity
Terbinafine impurity 12 is a chemical impurity associated with Terbinafine, an antifungal agent. This compound is primarily utilized in quality control and analytical assessments of Terbinafine formulations. Its identification is crucial for ensuring the purity and efficacy of pharmaceutical products containing Terbinafine. -
Drug Impurity
Rivastigmine impurity 6, also known as Rivastigmine N-oxide, is a chemical impurity associated with the drug Rivastigmine. This compound plays a significant role in quality control and characterization of pharmaceutical formulations. Its analytical assessment is essential for ensuring the purity and efficacy of Rivastigmine-based therapies in research and development settings. Rivastigmine impurity 6 is useful for various investigations into drug metabolism and safety. -
Drug Impurity
Salbutamol impurity 4 is a known impurity of the bronchodilator Salbutamol, primarily utilized in pharmaceutical analysis. This compound serves as a critical reference standard for assessing the purity and quality of Salbutamol formulations. Its presence and quantification are essential in ensuring compliance with regulatory standards in drug development and quality control processes. -
Drug Impurity
Fluphenazine impurity 5 is a minor impurity associated with the antipsychotic agent Fluphenazine. This compound serves as a critical standard for quality control and analytical validation in the production of pharmaceutical formulations containing Fluphenazine. Its characterization is essential for ensuring the safety, efficacy, and compliance of drug products in pharmaceutical research and development. -
Drug Impurity
Amodiaquine impurity 4 is a chemical impurity associated with the synthesis of Amodiaquine. Its characterization is essential for ensuring the purity and safety of pharmaceutical formulations. This impurity can be used in research applications focused on drug metabolism and pharmacokinetics, as well as regulatory compliance for quality control in manufacturing processes. -
Drug Impurity
1,11b-Dedihydrotetrabenazine is classified as a drug impurity. This compound serves as a critical reference standard in the analysis of tetrabenazine formulations, facilitating the assessment of quality and compliance in pharmaceutical development. It is essential for researchers evaluating the safety and efficacy of related therapeutic agents. -
Drug Impurity
Telmisartan impurity 2 is a chemical impurity associated with Telmisartan, primarily identified as a drug impurity. This compound is utilized in pharmaceutical research to ensure the purity and quality of Telmisartan formulations. Its presence and characterization are essential for regulatory compliance and safety evaluations in drug development processes. -
Drug Impurity
Tenofovir Impurity 6 is a chemical impurity associated with the antiviral drug Tenofovir, which targets the reverse transcriptase enzyme. This impurity may be relevant for analytical studies, quality control processes, and method development in the pharmaceutical research of Tenofovir and its formulations. Understanding the profile of this impurity is essential for ensuring the safety and efficacy of drug products. -
Drug Impurity
Citalopram impurity 4, chemically known as 3-Oxocitalopram, functions as a drug impurity associated with the antidepressant Citalopram. Its presence is important for stability studies and the evaluation of pharmaceutical formulations. This compound is significant in research related to drug development and quality control, enabling the assessment of the purity and safety of Citalopram products. -
Drug Intermediate
Levetiracetam impurity 9 is identified as a drug intermediate in the synthesis of Levetiracetam. This chemical is primarily utilized for the characterization and quality control of Levetiracetam formulations. Its presence serves as a reference standard in analytical assays and helps ensure the purity of pharmaceutical products. -
Drug Impurity
Tavarborol impurity 16 is a chemical impurity associated with the synthesis of Tavarborol. Its identification and characterization are essential for ensuring the quality and safety of Tavarborol-based formulations. This impurity is utilized in analytical research applications, particularly in the development and validation of analytical methods. -
Drug Impurity
Bedaquinoline impurity 18 is a significant impurity associated with Bedaquinoline, a compound known for its antitubercular activity. This impurity may be used in analytical applications to assess the purity of Bedaquinoline formulations and study its metabolic pathways. Understanding such impurities is crucial for ensuring drug safety and efficacy in tuberculosis research. -
Drug Impurity
Rivastigmine impurity 2 is a known impurity associated with Rivastigmine, a reversible inhibitor of acetylcholinesterase. This compound can be utilized for analytical research and quality control studies in the pharmaceutical industry. Its characterization is essential for the assessment of drug purity and stability in formulations containing Rivastigmine. -
Drug Impurity
Apixaban impurity 42 is a structural variant of the anticoagulant Apixaban. This impurity serves as a key reference standard in pharmacological research for assessing the purity of Apixaban formulations. It is utilized in stability testing, quality control, and method development in pharmaceutical laboratories to ensure compliance with regulatory standards. -
Drug Impurity
Rivaroxaban impurity 44 is a characterized impurity associated with the anticoagulant Rivaroxaban. This compound facilitates the examination of the drug's purity and stability during formulation development and quality control processes. It is essential for analytical research in pharmacology and toxicology, helping to ensure compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Sildenafil impurity 5 is a chemical impurity associated with Sildenafil, a well-known phosphodiesterase type 5 (PDE5) inhibitor. This reagent is crucial for quality control and characterization in pharmaceutical development, particularly in the assessment of the purity of Sildenafil formulations. It serves as a reference standard for analytical methods, ensuring compliance with regulatory requirements in drug manufacturing and research applications. -
Drug Impurity
Pimecrolimus impurity 7 is a known impurity associated with the drug Pimecrolimus, a selective calcineurin inhibitor. This compound is primarily used in pharmaceutical research to assess the purity and stability of Pimecrolimus formulations. It is essential for understanding the biochemical properties of drug products and is utilized in quality control processes within the pharmaceutical industry. -
Drug Impurity
Metoprolol impurity 7 is a chemical impurity associated with Metoprolol, a beta-adrenergic antagonist. This impurity is important for the quality control and validation of pharmaceutical formulations containing Metoprolol, enabling researchers to assess the purity of their compounds. Its characterization is crucial for ensuring compliance with regulatory standards in the development of cardiovascular therapies. -
Drug Impurity
Apixaban Impurity 32 is a known impurity associated with the anticoagulant Apixaban. This compound is essential for characterization and quality control in pharmaceutical research, particularly in the development and validation of analytical methods for Apixaban. It aids in ensuring the purity and safety of drug formulations containing Apixaban and is crucial for compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Lopinavir impurity 14 is a known impurity of the antiviral agent Lopinavir. This compound is primarily used in the assessment of drug purity and quality control during pharmaceutical research. It serves as a critical reference standard in analytical studies to ensure compliance with safety and efficacy regulations in drug development. -
Drug Impurity
Betamethasone dipropionate impurity 4 is a defined impurity arising from the synthesis of Betamethasone dipropionate. It serves as a critical reference standard for quality control and analytical assessments in pharmaceutical development. Its characterization is essential for ensuring the safety and efficacy of Betamethasone dipropionate formulations. -
Drug Impurity
Carvedilol impurity 6, also known as N-Isopropyl carvedilol, serves as a drug impurity related to the pharmaceutical compound Carvedilol. This reagent is essential for characterizing the purity and quality of Carvedilol formulations in research and development. Its presence and behavior can provide insights into the synthesis and metabolic pathways involving beta-blockers, contributing to pharmacological studies and safety assessments in drug development. -
Drug Impurity
Apixaban carboxylic acid O-desmethyl impurity is an impurity of Apixaban, specifically the carboxylic acid O-desmethyl derivative. This compound serves as a reference standard in analytical chemistry, helping to assess the purity and composition of Apixaban formulations. Its presence can be critical in the quality control and development of pharmacological studies involving Apixaban. -
Drug Impurity
Clozapine impurity 2 is a known impurity associated with the antipsychotic drug Clozapine. This compound is important for analytical chemistry applications, including the characterization and quality control of Clozapine formulations. Researchers studying drug metabolism and safety profiles may utilize this impurity for in-depth investigations into the pharmacological properties and potential effects of Clozapine. -
Drug Impurity
Gabapentin acid impurity 5 is a byproduct of gabapentin acid synthesis, classified as a drug impurity. This compound is typically studied to assess the purity and quality of pharmaceutical formulations. Its detection and characterization are critical for ensuring compliance with regulatory standards in drug development.
